LAM cells: “now you see it, now you don't”
European Respiratory Journal · 2026-11 · 68 (5) · 2601473
DOI: 10.1183/13993003.01473-2026 ↗Kurz gefasst
Editorial in der Zeitschrift European Respiratory Journal, online erschienen am 05.11.2026. Verfasst von Vera P Krymskaya. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, …. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Extract Pulmonary lymphangioleiomyomatosis (LAM) is a rare genetic lung disease, primarily affecting women, that is triggered by bi-allelic inactivating mutations of the tuberous sclerosis complex (TSC1/TSC2) genes [1, 2]. The loss of TSC2 function, with subsequent constitutive activation of the mechanistic target of rapamycin (mTOR) [3], is associated with formation of microscopic LAM lesions and lung cysts – leading to spontaneous pneumothoraces and progressive loss of pulmonary function, ultimately causing death or requiring lung transplantation [4].
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA krymskay@pennmedicine.upenn.edu.
Zitieren
APA
Krymskaya, V. P. (2026). LAM cells: “now you see it, now you don't”. European Respiratory Journal, 68(5), 2601473. https://doi.org/10.1183/13993003.01473-2026
Vancouver
Krymskaya VP. LAM cells: “now you see it, now you don't”. European Respiratory Journal. 2026;68(5):2601473. doi:10.1183/13993003.01473-2026
BibTeX
@article{Krymskaya2026,
author = {Krymskaya, Vera P},
title = {LAM cells: “now you see it, now you don't”},
journal = {European Respiratory Journal},
year = {2026},
volume = {68},
number = {5},
pages = {2601473},
doi = {10.1183/13993003.01473-2026}
}
EUVIMED